



Markets
/
Stocks
/
nasdaq-sny
/

Sanofi SA

SNY

View Detailed Chart

52.320USD

-1.219-2.28%

Close 04/25, 16:00（ET）Quotes delayed by 15 min

131.18BMarket Cap

21.67P/E TTM



Sanofi SA

52.320

-1.219-2.28%

Company

Intraday

30m

Today

-2.28%

5 Days

+2.79%

1 Month

-4.00%

6 Months

-3.72%

Year to Date

+8.48%

1 Year

+6.49%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts

BUY

Current Rating

64.122

Target Price

22.56%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

160

Total

Median

Average

Company name

Ratings

Analysts

Sanofi SA

SNY

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(4)

Buy(3)

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.585

Neutral

RSI(14)

47.025

Neutral

STOCH(KDJ)(9,3,3)

75.075

Neutral

ATR(14)

1.733

Low Volatility

CCI(14)

99.011

Neutral

Williams %R

22.936

Buy

TRIX(12,20)

-0.353

Sell

StochRSI(14)

57.321

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

52.332

Sell

MA10

51.706

Buy

MA20

52.236

Buy

MA50

54.740

Sell

MA100

52.364

Sell

MA200

52.968

Sell

News

More news coming soon, stay tuned...

Company

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Company codeSNY

CompanySanofi SA

CEOMr. Paul Hudson, Ph.D.

Websitehttps://www.sanofi.com/